Trxade Group, Inc. Gains 93.84%
Trxade Group, Inc. (MEDS:NASDAQ) soared at $16.36, a gain of 93.8%. On Mon, Jun 26, 2023, MEDS:NASDAQ hit a New 2-Week High of $16.36. The stock got featured on our News Catalysts scanner on Fri, Jun 23, 2023 at 05:52 PM in the 'MERGER' category. From Mon, Jun 12, 2023, the stock recorded 55.56% Up Days and 60.00% Green Days
About Trxade Group, Inc. (MEDS:NASDAQ)
Trxade Group Inc engages in designing and developing business to business web-based platform which provides buying and selling opportunities for pharmacies and national suppliers of the pharmaceutical industry. The products developed by the company are trxade.com which is a web-based pharmaceutical platform for promoting and trade among independent pharmacies and suppliers, inventoryrx.com which is also a platform for promoting and trading among suppliers and manufacturers nationally, pharmabayonline which provides access to pharmaceutical data analytics to United States based independent pharmacies, and rxguru which is a service based desktop software applications for providing drug pricing and analytics.
Top 10 Gainers:
- Trxade Group, Inc. (MEDS:NASDAQ), 93.84%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 81.36%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 77.55%
- Spark Networks SE (LOV:NASDAQ), 50.04%
- iMedia Brands, Inc. (IMBI:NASDAQ), 35.71%
- ACELYRIN INC. (SLRN:NASDAQ), 35.41%
- Shengfeng Development Limited (SFWL:NASDAQ), 33.2%
- Adagene Inc. (ADAG:NASDAQ), 30.37%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 28%
- Pharvaris N.V. (PHVS:NASDAQ), 27.76%